Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Senwen Feng"'
Autor:
Yu Liu, Ying Wang, Yuxiang Wang, Yu Xie, Yanfen Cui, Senwen Feng, Mengxia Yao, Bingjiang Qiu, Wenqian Shen, Dong Chen, Guoqing Du, Xin Chen, Zaiyi Liu, Zhenhui Li, Xiaotang Yang, Changhong Liang, Lei Wu
Publikováno v:
EClinicalMedicine, Vol 52, Iss , Pp 101562- (2022)
Summary: Background: Early prediction of treatment response to neoadjuvant chemotherapy (NACT) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer can facilitate timely adjustment of treatment regimens. We aimed to
Externí odkaz:
https://doaj.org/article/58042be77f39460ab797f75dc606a22e
Autor:
Senwen Feng, Junhao Liu, Li Hailiang, Jianfan Wen, Yujun Zhao, Xiaofeng Li, Guankun Lu, Peng Gao, Xiancheng Zeng
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101124- (2021)
Liver cancer was reported to be the sixth most frequently diagnosed cancer, and hepatocellular carcinoma (HCC) accounts for 75%-85% of primary liver cancer. Nevertheless, the concrete molecular mechanisms of HCC progression remain obscure, which is e
Externí odkaz:
https://doaj.org/article/e3636c143bba4f928e9b47d881c2dd23
Autor:
Yu Liu, Ying Wang, Senwen Feng, Zeyan Xu, Mengxia Yao, Xiaomei Huang, Pinxiong Li, Lei Wu, Chunling Liu, Xin Chen, Changhong Liang, Zaiyi Liu
Publikováno v:
Breast Cancer Research and Treatment. 197:515-523
This study aimed to determine whether post-neoadjuvant therapy (NAT) axillary ultrasound (AUS) could reduce the false-negative rate (FNR) of sentinel lymph node biopsy (SLNB). We also performed subgroup analyses to identify the appropriate patient fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7b1dcccdaae23a6f3907c3c74d5f1b
https://doi.org/10.1007/s10549-022-06817-8
https://doi.org/10.1007/s10549-022-06817-8
Autor:
Junhao Liu, Xiaofeng Li, Guankun Lu, Xiancheng Zeng, Senwen Feng, Peng Gao, Li Hailiang, Jianfan Wen, Yujun Zhao
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101124-(2021)
Translational Oncology
Translational Oncology
Highlights • Amplification of RAD54B promotes HCC progression by wnt/β-catenin pathway.
Liver cancer was reported to be the sixth most frequently diagnosed cancer, and hepatocellular carcinoma (HCC) accounts for 75%-85% of primary liver cance
Liver cancer was reported to be the sixth most frequently diagnosed cancer, and hepatocellular carcinoma (HCC) accounts for 75%-85% of primary liver cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbac18dd03fa6c86d23c85804d5e3b00
http://www.sciencedirect.com/science/article/pii/S1936523321001169
http://www.sciencedirect.com/science/article/pii/S1936523321001169